Financial Architects, Inc Isoray, Inc. Transaction History

Financial Architects, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$0.37 - $0.47 $370 - $470	-1,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$0.32 - $0.46 $320 - $460	1,000 New	1,000 $0
Q1 2019 May 03, 2019	SELL	$0.32 - $0.46 $320 - $460	-1,000 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$0.51 - $0.6 $510 - $600	1,000	1,000 $1,000

145K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.